Market Closed -
Other stock markets
|
Pre-market 02:26:48 am | |||
82.7 EUR | -2.71% | 83.12 | +0.51% |
Apr. 02 | Spain's Rovi Obtains US FDA Approval for Marketing Risvan as Schizophrenia Treatment | MT |
Mar. 12 | Rovi, Partners to Form Entity for Advanced Therapies R&D | MT |
- Stock Market
- Equities
- ROVI Stock
- News Laboratorios Farmaceuticos Rovi, S.A.
- MarketScreener Strategies